Generex Biotechnology Corp (NASDAQOTCBB:GNBT.OB)
| CAPS Rating |
|
|---|
GNBT.OB
VS S&P 500 (SPY)
GNBT.OB News and Commentary
- Generex Biotechnology Shares Plunged: What You Need to Know – The Motley Fool
- Why I Am Voting For Generex's Reverse Stock Split – SeekingAlpha
- Generex Shares Plunged: What You Need to Know – The Motley Fool
- Wall Street's Best Hidden Stocks – The Motley Fool
- Generex 's Acquisition Into the Direct to Consumer Diabetes Market Provides Synergistic Value – SeekingAlpha
- GNBT Shares Popped Then Plunged: What You Need to Know – The Motley Fool
- Generex: Do Development Drug Companies Have No Value? – SeekingAlpha
- News Next Week for Generex May Reduce Need for Reverse Split – SeekingAlpha
- Analyzing Generex and Throwing Darts With Pfizer's Craig Eagle – SeekingAlpha
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
174
Outperform
12
Underperform
All-Star Players
16
Outperform
4
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
